Brought to you by:
FDA issues updated safety communication on use of Endologix AFX endovascular grafts
The Food and Drug Administration (FDA) has issued an updated safety communication on the use of Endologix AFX endovascular grafts. This update includes a summary of information from a November 2021 meeting of the FDA’s Circulatory System Devices Panel of…
VAM travel scholarship applications available this month
Medical students and general surgery residents will be able to apply this month for travel scholarships to attend the 2022 Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM)—with the application period opening toward the end of the month. The…
SVS PAD course postponed
The new Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Skills Course has been postponed amid the COVID-19 pandemic recent surge in cases, the Society has announced. The course—which had been set to run Feb. 11–12—will now take place…
Deadlines near to submit VRIC and VAM abstracts
Abstract submissions for possible presentation at the 2022 Vascular Research Initiatives Conference (VRIC) and the 2022 Vascular Annual Meeting (VAM) in Boston are due Jan. 11 and Jan. 12, respectively. Submissions for VRIC, which emphasizes basic and translational vascular science,…
VIVID study on Duo venous stent system now fully enrolled, Vesper Medical announces
Vesper Medical recently announced the completion of enrollment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent system). VIVID enrolled its 160th patient earlier this month, marking completion of enrollment in the trial.…
‘Meet the Experts’ webinars now available OnDemand
Society for Vascular Surgery (SVS) members now have another chance to “Meet the Experts,” via computer screen and at no charge. Three of the “Meet the Experts” webinars held in spring and summer are now available on SVS OnDemand, part…
VESS: A society primed for young vascular surgeons, trainees and medical students
Welcome to December where the calendar is filled with abstract and registration deadlines to various meetings through the summer of 2022. In this month‘s column, we are highlighting the Vascular and Endovascular Surgery Society (VESS). Formerly known as the Peripheral…
FDA approves two pediatric venous thromboembolism indications for rivaroxaban
The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of…
CLI at a crossroads: Which direction now?
Vascular surgery once again finds itself at a crossroads, Michael Belkin, MD, chief of the division of vascular and endovascular surgery at Brigham and Women’s Hospital in Boston, told the Western Vascular Society (WVS) annual meeting (Oct. 16–19) in Jackson…
Nominate ‘giver, doer’ for Excellence in Community Service Award
The Society for Vascular Surgery (SVS) is asking members to consider who among the many excellent vascular surgeons they may know in community practice might be worthy of nomination for the 2022 SVS Excellence in Community Service Award. Applications for…